Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Am J Pathol
2009 Feb 01;1742:661-70. doi: 10.2353/ajpath.2009.080755.
Show Gene links
Show Anatomy links
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.
Martelli MP
,
Sozzi G
,
Hernandez L
,
Pettirossi V
,
Navarro A
,
Conte D
,
Gasparini P
,
Perrone F
,
Modena P
,
Pastorino U
,
Carbone A
,
Fabbri A
,
Sidoni A
,
Nakamura S
,
Gambacorta M
,
Fernández PL
,
Ramirez J
,
Chan JK
,
Grigioni WF
,
Campo E
,
Pileri SA
,
Falini B
.
???displayArticle.abstract???
A fusion gene, echinoderm microtubule associated protein like 4-anaplastic lymphoma kinase (EML4-ALK), with transforming activity has recently been identified in a subset of non-small cell lung cancer (NSCLC), but its pathogenetic, diagnostic, and therapeutic roles remain unclear. Both frequency and type of EML4-ALK transcripts were investigated by reverse transcription PCR in 120 frozen NSCLC specimens from Italy and Spain; non-neoplastic lung tissues taken far from the tumor were used as controls. In cases carrying the fusion transcript, we determined EML4-ALK gene and protein levels using fluorescence in situ hybridization, Western blotting, and immunoprecipitation. We also analyzed ALK protein levels in paraffin samples from 662 NSCLC specimens, including the 120 cases investigated in the molecular studies. EML4-ALK transcripts (variants 1 and 3) were detected in 9 of 120 NSCLC samples but were not specific for NSCLC since they were also found in non-cancerous lung tissues taken far from the tumor. Notably, no transcripts were detected in matching tumor samples from these patients. Fluorescence in situ hybridization analysis of cases expressing EML4-ALK transcripts showed that only a minority of cells harbored the EML4-ALK gene. None of these cases was found to express the EML4-ALK protein as examined by immunohistochemistry, Western blotting, and immunoprecipitation. The EML4-ALK transcript cannot be regarded as a specific diagnostic tool for NSCLC. Our results show therefore that the causal role and value of EML4-ALK as a therapeutic target remain to be defined.
Allouche,
ALK is a novel dependence receptor: potential implications in development and cancer.
2007, Pubmed
Allouche,
ALK is a novel dependence receptor: potential implications in development and cancer.
2007,
Pubmed
Amin,
Pathobiology of ALK+ anaplastic large-cell lymphoma.
2007,
Pubmed
Benharroch,
ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
1998,
Pubmed
Beylot-Barry,
Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.
1998,
Pubmed
Camilleri-Broët,
ALK is not expressed in Hodgkin disease.
2001,
Pubmed
Choi,
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.
2008,
Pubmed
Delsol,
A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.
1997,
Pubmed
Falini,
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
2002,
Pubmed
Falini,
ALK+ lymphoma: clinico-pathological findings and outcome.
1999,
Pubmed
Falini,
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
1998,
Pubmed
Falini,
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
1999,
Pubmed
Fukuyoshi,
EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.
2008,
Pubmed
,
Echinobase
Galkin,
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.
2007,
Pubmed
Houtman,
Echinoderm microtubule-associated protein like protein 4, a member of the echinoderm microtubule-associated protein family, stabilizes microtubules.
2007,
Pubmed
,
Echinobase
Inamura,
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
2008,
Pubmed
,
Echinobase
Jemal,
Cancer statistics, 2006.
2006,
Pubmed
Koivunen,
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
2008,
Pubmed
Lawrence,
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
2000,
Pubmed
Lynch,
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
2004,
Pubmed
McDermott,
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.
2008,
Pubmed
Meyerson,
Cancer: broken genes in solid tumours.
2007,
Pubmed
Morris,
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
1994,
Pubmed
Orscheschek,
Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis?
1995,
Pubmed
Perner,
EML4-ALK fusion lung cancer: a rare acquired event.
2008,
Pubmed
Pollmann,
Human EML4, a novel member of the EMAP family, is essential for microtubule formation.
2006,
Pubmed
Pulford,
Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
1997,
Pubmed
Pulford,
Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma.
1999,
Pubmed
Rikova,
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
2007,
Pubmed
Shinmura,
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
2008,
Pubmed
Soda,
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
2007,
Pubmed
,
Echinobase
Soda,
A mouse model for EML4-ALK-positive lung cancer.
2008,
Pubmed
Stein,
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
2000,
Pubmed
Tang,
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
2005,
Pubmed
Thomas,
Genomic approaches to lung cancer.
2006,
Pubmed
